Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 11, 16:00
Pharma Mar Price to Book Value : 5.72 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 5.72 |
| September 10, 2026 | 5.72 |
| September 09, 2026 | 5.72 |
| September 08, 2026 | 5.72 |
| September 04, 2026 | 5.72 |
| September 03, 2026 | 5.72 |
| September 02, 2026 | 5.72 |
| September 01, 2026 | 5.72 |
| August 31, 2026 | 5.72 |
| August 28, 2026 | 5.887 |
| August 27, 2026 | 5.887 |
| August 26, 2026 | 5.296 |
| August 25, 2026 | 5.296 |
| August 24, 2026 | 5.296 |
| August 21, 2026 | 5.296 |
| August 20, 2026 | 5.296 |
| August 19, 2026 | 5.296 |
| August 18, 2026 | 5.296 |
| August 17, 2026 | 5.296 |
| August 14, 2026 | 5.296 |
| August 13, 2026 | 5.296 |
| August 12, 2026 | 5.296 |
| August 11, 2026 | 5.296 |
| August 10, 2026 | 5.296 |
| August 07, 2026 | 5.296 |
| Date | Value |
|---|---|
| August 06, 2026 | 5.296 |
| August 05, 2026 | 5.296 |
| August 04, 2026 | 5.205 |
| August 03, 2026 | 5.205 |
| July 31, 2026 | 5.205 |
| July 30, 2026 | 5.205 |
| July 29, 2026 | 5.205 |
| July 28, 2026 | 5.205 |
| July 27, 2026 | 5.205 |
| July 24, 2026 | 5.205 |
| July 23, 2026 | 5.205 |
| July 22, 2026 | 5.205 |
| July 21, 2026 | 5.205 |
| July 20, 2026 | 5.205 |
| July 17, 2026 | 5.205 |
| July 16, 2026 | 5.205 |
| July 15, 2026 | 5.205 |
| July 14, 2026 | 5.205 |
| July 13, 2026 | 5.496 |
| July 10, 2026 | 5.496 |
| July 09, 2026 | 5.704 |
| July 08, 2026 | 5.704 |
| July 07, 2026 | 4.806 |
| July 06, 2026 | 4.806 |
| July 02, 2026 | 4.806 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Oryzon Genomics SA | 2.153 |
| Grifols SA | 0.8104 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alkermes Plc | 4.259 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
Price to Book Value Related Metrics
| PE Ratio | 25.29 |
| PS Ratio | 6.458 |
| PEG Ratio | 0.6125 |
| Price to Free Cash Flow | 26.17 |
| Price | 94.60 |
| Earnings Yield | 3.95% |
| Market Cap | 1.640B |
| PEGY Ratio | 0.5951 |
| Operating PE Ratio | 44.61 |
| Normalized PE Ratio | 25.29 |